Alert was issued on insulin pumps made by American medical equipment giant Medtronic. In India, the insulin pumps used are MiniMed 508 and MiniMed Paradigm series.
Bottle of Lies by journalist Katherine Eban accuses Indian pharma firms of fudging data on quality control and toxic impurities, among other major lapses.
The drugs — eszopiclone (Lunesta), zaleplon (Sonata) and zolpidem (Ambien, Ambien CR, Edluar, Intermezzo, and Zolpimist) — are commonly prescribed in India too.
Noida-based B.Jain Pharmaceuticals exports homoeopathy medicines to several countries, including US. It also sells products in India for treatment of diabetes, liver ailments.
'Jugaad', translated as creative improvisation, is credited with the rise in technology and drug making in India. But it can have a darker connotation -- get it done at all costs.
Imposition of formal rights and digital compliance mechanisms introduces new expectations for both employers and workers. This transition will require sustained awareness efforts.
While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.
Wing Commander Namansh Syal is survived by his wife, their 6-year-old daughter and his mother. Back in his native village, relatives and neighbours wait for his remains for last rites.
It is a brilliant, reasonably priced, and mostly homemade aircraft with a stellar safety record; only two crashes in 24 years since its first flight. But its crash is a moment of introspection.
We are so glad for news publications like The Print which bring to light and unsuspecting customers the reality scenarios this time the controversial generic drug business in India as soon Govt to help patients wants Docs to prescribe generic instead of prescription drug which is a v.good move but the Drug Regulators then have to br more professional and honest in their Inspections.
We know the attitude of most Regulators and strict and honest they are with their Inspections one major one is…informing the Cos in advance of their visit !!
We are so glad for news publications like The Print which bring to light and unsuspecting customers the reality scenarios this time the controversial generic drug business in India as soon Govt to help patients wants Docs to prescribe generic instead of prescription drug which is a v.good move but the Drug Regulators then have to br more professional and honest in their Inspections.
We know the attitude of most Regulators and strict and honest they are with their Inspections one major one is…informing the Cos in advance of their visit !!